TABLE 1

Clinical Characteristics of Subjects

CharacteristicPD group (n = 49)PSP group (n = 19)MSA group (n = 24)Healthy controls (n = 21)
Age (y)62 ± 1168 ± 862 ± 1161 ± 12
Sex (M/F), n21/289/108/166/15
Symptom duration (y)5.1 ± 6.03.9 ± 2.13.0 ± 1.7NA
Hoehn–Yahr stage2.0 ± 1.03.4 ± 1.3*4.0 ± 1.2†NA
UPDRS III score20.4 ± 13.325.5 ± 12.735.4 ± 16.5NA

  • ↵* P < 0.05 for PD vs. PSP.

  • ↵† P < 0.05 for PD vs. MSA.

  • NA = not applicable.

  • Values are reported as mean ± SD unless otherwise indicated.